Medindia

X

GSK’s Combination Meningitis Vaccine Receives FDA Approval

by Kathy Jones on  June 15, 2012 at 10:43 PM Drug News   - G J E 4
GlaxoSmithKline has announced that its combination meningitis vaccine, MenHibrix has been approved by the US Food and Drug Administration as a protective vaccination for infants against two bacterial diseases.
 GSK’s Combination Meningitis Vaccine Receives FDA Approval
GSK’s Combination Meningitis Vaccine Receives FDA Approval
Advertisement

MenHibrix is a combination of GSK's meningococcal and Hib vaccines and is administered in a four-dose series at 2, 4, 6 and 12 through 15 months of age. The company said that the vaccine will prevent diseases caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.

Advertisement
Commenting on the approval, GSK Vaccines vice president Leonard Friedland said, "MenHibrix gives healthcare providers the option of combining Hib immunization with meningococcal C and Y immunization without increasing the number of shots for infants and toddlers."

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.

You May Also Like

View All >>